Although classical chemotherapeutics such as 5-fluorouracil (5-FU), cisplatin, and mitomycin C indirectly raise the p53 level (7), they are not direct modulators of this pathway and CRC’s p53-status seems not to be a determinant for significant treatment success with these drugs (8). Here, TP53 is linked to colorectal carcinoma.